DK656687D0 - Bakterielle antigener, antistoffer, vacciner og fremgangsmaade til fremstilling deraf - Google Patents

Bakterielle antigener, antistoffer, vacciner og fremgangsmaade til fremstilling deraf

Info

Publication number
DK656687D0
DK656687D0 DK656687A DK656687A DK656687D0 DK 656687 D0 DK656687 D0 DK 656687D0 DK 656687 A DK656687 A DK 656687A DK 656687 A DK656687 A DK 656687A DK 656687 D0 DK656687 D0 DK 656687D0
Authority
DK
Denmark
Prior art keywords
gbs
polysaccharide
vaccines
antibodies
procedures
Prior art date
Application number
DK656687A
Other languages
English (en)
Other versions
DK175487B1 (da
DK656687A (da
Inventor
Dennis L Kasper
Harold J Jennings
Nancy J Levy
Michael R Wessels
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Publication of DK656687D0 publication Critical patent/DK656687D0/da
Publication of DK656687A publication Critical patent/DK656687A/da
Application granted granted Critical
Publication of DK175487B1 publication Critical patent/DK175487B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198706566A 1986-04-16 1987-12-15 Bakterielle antigener, vacciner og fremgangsmåder til fremstilling af antigenet DK175487B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85284086A 1986-04-16 1986-04-16
US85284086 1986-04-16
US8700845 1987-04-14
PCT/US1987/000845 WO1987006267A1 (en) 1986-04-16 1987-04-14 Bacterial antigens, antibodies, vaccines, and methods of manufacture

Publications (3)

Publication Number Publication Date
DK656687D0 true DK656687D0 (da) 1987-12-15
DK656687A DK656687A (da) 1987-12-15
DK175487B1 DK175487B1 (da) 2004-11-08

Family

ID=25314361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198706566A DK175487B1 (da) 1986-04-16 1987-12-15 Bakterielle antigener, vacciner og fremgangsmåder til fremstilling af antigenet

Country Status (7)

Country Link
EP (1) EP0302887B1 (da)
JP (2) JP2754000B2 (da)
AT (1) ATE107703T1 (da)
CA (1) CA1305918C (da)
DE (1) DE3750139T2 (da)
DK (1) DK175487B1 (da)
WO (1) WO1987006267A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp A vaccine made from polysaccharide and protein
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
WO1991004335A1 (en) * 1989-09-18 1991-04-04 Brigham And Women's Hospital Enzymatic generation and recovery of group b streptococcus type iii capsular oligosaccharides
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
JP2631035B2 (ja) * 1991-03-12 1997-07-16 アメリカ合衆国 多糖類−タンパク質複合体
FR2682388B1 (fr) * 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
NZ248766A (en) * 1992-09-24 1996-11-26 Ca Nat Research Council Capsular polysaccharide-protein conjugate vaccine against group b streptococcus type ii or v
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
AU722078B2 (en) * 1992-11-02 2000-07-20 Brigham And Women's Hospital Conjugate vaccine against group B Streptococcus
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
ES2141213T3 (es) * 1994-08-19 2000-03-16 Nestle Sa Polisacarido ramificado, microorganismo que lo produce y composiciones que lo contienen.
IL121585A0 (en) * 1995-06-07 1998-02-08 Alberta Res Council Immunogenic and immunostimulatory oligosaccharide compositions and methods of preparing and using them
US5695768A (en) * 1995-06-07 1997-12-09 Alberta Research Council Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
US5866132A (en) * 1995-06-07 1999-02-02 Alberta Research Council Immunogenic oligosaccharide compositions
US6284884B1 (en) * 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
JP4402290B2 (ja) * 1997-10-17 2010-01-20 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 新規な乳酸菌種
HUE029265T2 (en) * 2008-10-27 2017-02-28 Glaxosmithkline Biologicals Sa Method of purifying carbohydrates from the group streptococci
CN115572716B (zh) * 2022-09-30 2023-06-16 云南沃森生物技术股份有限公司 抗iii型b群链球菌荚膜多糖单克隆抗体及杂交瘤细胞株

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207414A (en) * 1978-08-16 1980-06-10 President And Fellows Of Harvard College Polysaccharide antigens
US4413057A (en) * 1980-04-14 1983-11-01 Merck & Co., Inc. Group B streptococcal capsular polysaccharides
US4356263A (en) * 1980-06-09 1982-10-26 President And Fellows Of Harvard College Method of making a polysaccharide vaccine

Also Published As

Publication number Publication date
EP0302887A1 (en) 1989-02-15
EP0302887A4 (en) 1989-11-20
JP2754000B2 (ja) 1998-05-20
JPH01500561A (ja) 1989-03-01
DK175487B1 (da) 2004-11-08
EP0302887B1 (en) 1994-06-22
CA1305918C (en) 1992-08-04
DE3750139T2 (de) 1994-10-06
ATE107703T1 (de) 1994-07-15
DE3750139D1 (de) 1994-07-28
DK656687A (da) 1987-12-15
WO1987006267A1 (en) 1987-10-22
JPH08277298A (ja) 1996-10-22

Similar Documents

Publication Publication Date Title
DK656687A (da) Bakterielle antigener, antistoffer, vacciner og fremgangsmaade til fremstilling deraf
DK1051506T3 (da) Fremgangsmåde til ekstraktion og isolation af bakterielle kapsel-polysaccharider til anvendelse som vaccine eller sammenkoblet med proteiner som konjugerede vacciner
NO308413B1 (no) Antigen blanding, DNA-segment som koder for et antigen, rekombinant vektor og vertscelle som innbefatter DNA-segmentet samt anvendelser av et antigen
FI883876A0 (fi) Menetelmä rokotteen valmistamiseksi streptokokki-infektioita vastaan
NO975434L (no) Fremgangsmåte for fremstilling av influensa hemagglutinin multivalente vaksiner
NZ223009A (en) Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
DK341679A (da) Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf
DE3175677D1 (en) Polysaccharide antigen from streptococcus and vaccines
FI924457A (fi) Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
DE68915046D1 (de) Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff.
ES8401722A1 (es) Procedimiento de obtencion de vacunas contra el patogeno h influenzae tipo b.
DK421486A (da) Polydisperse native pseudomonas-flagella(h)-antigener (fag) og fremgangsmaade til deres udvinding
KR890000106A (ko) 원생성 기생충 예방용 백신
DK0809653T3 (da) Helicobacter pylori-antigen
Ivshina Methods for obtaining specific immune sera against bacteria of the genus Rhodococcus.

Legal Events

Date Code Title Description
PUP Patent expired